DE69924987D1 - Pharmazeutische zusammensetzungen enthaltend syntethisch natürliche progesteron und estradiol und verfahren zur herstellung derselben - Google Patents

Pharmazeutische zusammensetzungen enthaltend syntethisch natürliche progesteron und estradiol und verfahren zur herstellung derselben

Info

Publication number
DE69924987D1
DE69924987D1 DE69924987T DE69924987T DE69924987D1 DE 69924987 D1 DE69924987 D1 DE 69924987D1 DE 69924987 T DE69924987 T DE 69924987T DE 69924987 T DE69924987 T DE 69924987T DE 69924987 D1 DE69924987 D1 DE 69924987D1
Authority
DE
Germany
Prior art keywords
syntethically
estradiol
production
pharmaceutical compositions
compositions contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69924987T
Other languages
English (en)
Other versions
DE69924987T2 (de
Inventor
Benoit Agnus
Antoine Besins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Besins International SAS
Original Assignee
Laboratoires Besins Iscovesco SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Besins Iscovesco SA filed Critical Laboratoires Besins Iscovesco SA
Application granted granted Critical
Publication of DE69924987D1 publication Critical patent/DE69924987D1/de
Publication of DE69924987T2 publication Critical patent/DE69924987T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE69924987T 1998-03-09 1999-03-08 Pharmazeutische Zusammensetzung enthaltend synthetisch natürliches Progesteron und Östradiol und Verfahren zur Herstellung derselben Expired - Lifetime DE69924987T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9802830 1998-03-09
FR9802830A FR2775599B1 (fr) 1998-03-09 1998-03-09 Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
PCT/FR1999/000515 WO1999045932A1 (fr) 1998-03-09 1999-03-08 Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation

Publications (2)

Publication Number Publication Date
DE69924987D1 true DE69924987D1 (de) 2005-06-02
DE69924987T2 DE69924987T2 (de) 2006-06-08

Family

ID=9523802

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69924987T Expired - Lifetime DE69924987T2 (de) 1998-03-09 1999-03-08 Pharmazeutische Zusammensetzung enthaltend synthetisch natürliches Progesteron und Östradiol und Verfahren zur Herstellung derselben

Country Status (13)

Country Link
US (1) US6656929B1 (de)
EP (1) EP1061929B1 (de)
KR (1) KR20010034573A (de)
AT (1) ATE293979T1 (de)
AU (1) AU3259099A (de)
BR (1) BR9908622A (de)
CA (1) CA2323696C (de)
DE (1) DE69924987T2 (de)
DK (1) DK1061929T3 (de)
ES (1) ES2246578T3 (de)
FR (1) FR2775599B1 (de)
PT (1) PT1061929E (de)
WO (1) WO1999045932A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FR2821555B1 (fr) 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312927A1 (en) * 2010-06-18 2011-12-22 Satish Kumar Nachaegari Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
WO2016018993A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド １７−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399243A2 (fr) * 1974-04-23 1979-03-02 Aries Robert Perfectionnements aux procedes, dispositifs et produits pour l'implantation d'hormones destinees a favoriser la croissance des animaux d'embouche
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19718012C1 (de) * 1997-04-29 1998-10-08 Jenapharm Gmbh Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe

Also Published As

Publication number Publication date
AU3259099A (en) 1999-09-27
EP1061929B1 (de) 2005-04-27
BR9908622A (pt) 2000-11-14
KR20010034573A (ko) 2001-04-25
ES2246578T3 (es) 2006-02-16
WO1999045932A1 (fr) 1999-09-16
DK1061929T3 (da) 2005-08-29
DE69924987T2 (de) 2006-06-08
CA2323696A1 (fr) 1999-09-16
FR2775599A1 (fr) 1999-09-10
US6656929B1 (en) 2003-12-02
PT1061929E (pt) 2005-09-30
CA2323696C (fr) 2010-04-27
EP1061929A1 (de) 2000-12-27
ATE293979T1 (de) 2005-05-15
FR2775599B1 (fr) 2001-08-17

Similar Documents

Publication Publication Date Title
DE69924987D1 (de) Pharmazeutische zusammensetzungen enthaltend syntethisch natürliche progesteron und estradiol und verfahren zur herstellung derselben
ATE375729T1 (de) Verfahren zur herstellung eines pharmazeutischen kaugummis
PT1075191E (pt) Composicoes de fito esterol
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
DE69718662D1 (de) Magnesium(-)hydroxycitrat, verfahren zur herstellung, anwendung und pharmazeutische zusammensetzungen, die sie enthalten
GR3034162T3 (en) Liposome-encapsulated taxol, its preparation and its use
RS49756B (sr) Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
AU3254395A (en) Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
DE69636989D1 (de) Bioaktive lasttragende zusammensetzungen zum knochenverbund
ATE217192T1 (de) Kombinationsprodukt zur kontrazeption enthaltend progesteronantagonisten und gestagenen
ATE171069T1 (de) Transdermale verhütungsmittelformulierung, verfahren und vorrichtung
DE69924846D1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
NO994233D0 (no) Sterol-estere i faste, tabletterte doseringsformer
BG105275A (en) Tan-1057 derivatives
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
HU9503579D0 (en) Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
GR3034803T3 (en) Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets
CA2421302A1 (en) 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
UA30798A (uk) Спосіб пролонгованої терапії онкологічних хворих
UA39044A (uk) Склад для лікування хвороб пародонта
RS49595B (sr) Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti
BR9902715A (pt) Formas em acetato, com ou sem acrìlico, para confecção de próteses provisórias
UA49201A (uk) Замінник кісткового борошна

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES BESINS INTERNATIONAL, PARIS, FR

8364 No opposition during term of opposition